Turning a corner: Private market posts best month in yearsCore private market metrics suggest positive momentum is brewing and investor sentiment is improving
Turning a corner: Private market posts best month in years
Trading
Data
Solutions
Insights
About
Human Longevity was founded in 2013 by J. Craig Venter, Peter Diamandis, and Robert Hariri. The company has not officially endorsed a plan to participate in an IPO. These comments should not be interpreted to mean that the company is formally pursuing or foregoing an IPO.
Human Longevity is a genomics-based health intelligence company creating the world’s largest and most comprehensive database of whole genome, phenotype, and clinical data. The company's mission is "to extend healthy human life by revolutionizing human health and transforming the practice of medicine." The company has acquired Cypher Genomics and DoctorsForMe. Human Longevity, based in San Diego, has raised $330 million in venture capital funding from investors including Emerging Technology Partners, Threshold, StartUp Health, OS Fund, Illumina Ventures, GE Ventures, Celgene, and Amino Capital. The company has not disclosed recent valuation information, but in 2018 Human Longevity reported a significant drop in valuation, falling from $1.6 billion to $310 million.
Human Longevity is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
If you own Human Longevity pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.
Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.
Human Longevity is a private company and not publicly traded.
If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.
| Date | Funding Round | Funding Raised | Price per Share | Last Known Valuation |
|---|---|---|---|---|
| 3/13/2023 | Series B-1 and B-2 | $17.42MM raised | $XXX.XX | $XXX.XX |
| 11/6/2019 | Series A-1 and A-2 | $52.06MM raised | $XXX.XX | $XXX.XX |
